Why the study?
Does flecainide acetate improve conversion to sinus rhythm in patients with supraventricular arrhythmias?
Population
50 patients exhibiting supraventricular arrhythmias.
Design
Case_series
Follow-up
Mean period of 7.4 +/- 9 hours for conversion
Authors
Loading...
May warrant consideration in short-duration cases but should not change practice; leaves open confirmation in randomized trials.
Does flecainide acetate improve conversion to sinus rhythm in patients with supraventricular arrhythmias?
Flecainide is an effective agent for converting atrial fibrillation and supraventricular tachycardias to sinus rhythm, particularly for arrhythmias of shorter duration.
Goy et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: